| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Officer | Mar 02, 2020 | Option Exercise | $193.84 | 21,667 | 4,199,931 | 35,972 | Apr 07, 2020, 06:30 PM | |
| AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Officer | Mar 02, 2020 | Option Exercise | $193.84 | 21,667 | 4,199,931 | 35,972 | Mar 04, 2020, 02:24 PM | |
| AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Officer | Dec 31, 2019 | Option Exercise | $191.17 | 1,031 | 197,096 | 14,305 | Jan 02, 2020, 05:55 PM | |
| AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Officer | Apr 03, 2019 | Option Exercise | $145.71 | 871 | 126,913 | 15,336 | Apr 05, 2019, 03:15 PM | |
| AGN | Allergan plc | Nicholson C. David | EVP Chief R&D Officer | Dec 31, 2018 | Option Exercise | $133.66 | 1,150 | 153,709 | 16,207 | Jan 03, 2019, 12:00 AM | |
| AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Apr 03, 2018 | Option Exercise | $164.74 | 871 | 143,489 | 17,357 | Apr 05, 2018, 07:01 PM | |
| AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Dec 29, 2017 | Option Exercise | $163.58 | 1,086 | 177,648 | 18,228 | Jan 02, 2018, 04:43 PM | |
| AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Aug 04, 2017 | Option Exercise | $242.65 | 3,898 | 945,850 | 13,040 | Aug 07, 2017, 08:05 PM | |
| AGN | Allergan plc | Nicholson C. David | Chief R&D Officer | Apr 03, 2017 | Option Exercise | $237.68 | 8,835 | 2,099,903 | 16,938 | Apr 04, 2017, 04:23 PM |
Menu